Navigation Links
LaVoie Group Adds Interleukin Genetics to its Life Science Agency Roster
Date:4/14/2008

SALEM, Mass., April 14 /PRNewswire/ -- LaVoie Group, a full-service provider of public relations, investor relations, corporate communications, and marketing strategy to life science clients, today announced that it has been selected as public relations agency of record by Interleukin Genetics (Amex: ILI).

Donna L. LaVoie, President & CEO, commented, "With personalized medicine top of mind across a number of different constituencies, Interleukin Genetics is well positioned to capitalize on its strengths in genetics research to develop a series of innovative preventive products. LaVoie Group looks forward to continue helping Interleukin communicate its story."

About Interleukin

Interleukin Genetics, Inc. (Amex: ILI) is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin currently offers an array of Nutraceuticals and OTCeuticals(R), including Ginkoba(R), Ginsana(R) and Venastat(R) which are sold at the nation's largest food, drug and mass retailers, and has commercialized genetic tests for periodontal disease risk assessment, cardiovascular risk assessment, and general nutrition assessment. Interleukin is headquartered in Waltham, MA. For more information about Interleukin and its ongoing program
'/>"/>

SOURCE LaVoie Group
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. LaVoie Group Adds Two New Companies to Its Life Science Client Roster
2. Broad-based group of physicians calls for improvement in stroke treatment
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
5. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure
6. New Research Uncovers how to Build and Maintain an Effective Competitive Intelligence Group
7. AMERIGROUP to Acquire Memphis Health Plan
8. Securians Minnesota Life Continues to Climb Group Life Rankings
9. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
10. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
11. Group B Strep: A Threat to Newborns That Doesnt Have to Be
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...ER HONORED FOR CAREER OF SCIENTIFIC DISCOVERY IN M... The Radiologic Society of North A...ith its "Outstanding Researcher of The Year" Award...ho has made original significant contributions to ...arch. Dr. Weissleder is Professor at Harvard Medi...
(Date:12/1/2008)...s awarded over half a million dollars to qualified...e/ -- UCB, The Epilepsy Company (TM), will honor ...larship(TM) at a reception in Seattle, WA on Sunda... Annual Meeting. The scholarship is awarded to in...pilepsy, and who seek personal growth through high...
(Date:12/1/2008)...Calif., Dec. 1 Transcept Pharmaceu...utical company, announced today that,Glenn A. Ocl... scheduled to,participate at the RBC Capital Mark...n a panel entitled "Delivering Novel Drug Solution...on is scheduled to take place on Thursday, Decembe...
(Date:12/1/2008)...n group,s new resource helps Americans cut prescri... , WASHINGTON, Dec. 1 /PRNewswire-USNewswire/ -... now available for free to consumers to help fend ...gs. Unveiled today by the Partnership for Safe Me...consumers ensure the safety of their prescription ...
Breaking Medicine News(10 mins):Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 2Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 3Health News:Unique Scholarship Helps People Affected by Epilepsy Fulfill Life Ambitions 2Health News:Unique Scholarship Helps People Affected by Epilepsy Fulfill Life Ambitions 3Health News:Unique Scholarship Helps People Affected by Epilepsy Fulfill Life Ambitions 4Health News:Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel 2Health News:Partnership for Safe Medicines Arms Public Against Counterfeit Drugs 2Health News:Partnership for Safe Medicines Arms Public Against Counterfeit Drugs 3Health News:Partnership for Safe Medicines Arms Public Against Counterfeit Drugs 4
...g for abdominal aortic aneurysms can sharply reduc... among men age 65// and older, according to a new ...e odds of death nearly in half for men ages 65 to ...s among women. However, men who received screenin...
...rted in March this year continues unabated. One mo...ands following reports that animals fed the brands... Yet another US pet food manufacturer has recalle... animals vomiting and experiencing kidney problems...
...which has surprised even scientists. It is only on...tle as 25% of its tissue. This process of regenera... is published in The Journal of Biological chemist...he goings-on in cells, the way they regenerate, wh...
...ttlement Programme, UN-Habitat and cola giant Coca...tter community //access to safe drinking water and...vestment of $300,000. The project in India will b...a Pradesh. Working in association with local non-g...
Other Medicine News:Health News:Screening for Abdominal Aortic Aneurysms Saves Men's Lives 2Health News:Two More Pet Food Products Recalled in US 2Health News:Two More Pet Food Products Recalled in US 3Health News:Liver Regeneration Unplugged 2Health News:Campaign for Safe Drinking Water in India, Nepal 2
(Date:11/25/2008)...Nov. 25 Pharmacyclics, I...mpany has completed a Phase 1,clinical trial with...mall-molecule Factor VIIa inhibitor. The trial was...evaluate the safety and pharmacologic effect of,P...ulted in a linear dose,response in the Internatio...
(Date:11/25/2008)... CardioVascular,BioThera...d today that it has,dosed the first patient in No...inical trial to treat patients with severe coronar...treatment of CORonary heart Disease) trial will in...rolled doses in approximately 120,patients with s...
(Date:11/24/2008)...ov. 24 Domino,s Pizza (NYSE: DPZ..., is gearing up to raise dough for,the kids of St...th annual,Thanks and Giving campaign. Domino,s cu...ion at point of purchase to benefit the children o...ver the phone or when ordering online at, www.dom...
(Date:11/24/2008)...tic Cancer Awareness Month , , Oak Brook, I...can Society for Gastrointestinal Endoscopy (ASGE) ...ng up this November to raise awareness about pancr... and the resources that are available for them. ,...ause of cancer deaths in the U.S. In 2008, an esti...
Breaking Medicine Technology:Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6HCM Announces Substantial Growth in 2007 3525 1HCM Announces Substantial Growth in 2007 3525 2Yale scientists create artificial cells that boost the immune response to cancer 2319 1Yale scientists create artificial cells that boost the immune response to cancer 2319 2The Leukemia 26 Lymphoma Society Offers Crucial Help at a Critical Time 12718 1The Leukemia 26 Lymphoma Society Offers Crucial Help at a Critical Time 12718 2Video 3A YMCAs Commit to Helping Americans Keep Their New Years Resolutions in Support of Health and Well Being 12714 1
3.2% Tryptone, 2.0% Yeast Extract, 0.5% Sodium Chloride, pH 7.5.
For use in implant arthroplasty associated with comminuted fractures, or rheumatoid, degenerative or post-traumatic disease of the radial head. Designed for higher demand patients requiring superior
For connection to the bipolar output of electrosurgical generators.
This legless table has adjustable height and round post. Pad sold separately.
Medicine Products: